Bedrock Periodontal Longevity: a specialist partner for your physician practice.
If you are running a physician-led medicine practice in Austin, you are already managing cardiovascular, metabolic, cognitive, and inflammatory risk. Bedrock Periodontal Longevity is the periodontal arm of that plan.
A specialist workup with a report your team can use.
- — A comprehensive periodontal and peri-implant workup.
- — Targeted oral microbial testing (OralDNA MyPerioPath, Bristle metagenomics, or Viome saliva RNA — chosen by case).
- — A structured written report you can drop into your chart, with pathogen counts, clinical findings, imaging summary, and a staged treatment plan.
- — Coordinated recall so your patient's oral status is retested on a cadence that matches the rest of their program.
Clear scope, on purpose.
- — We will not order ApoE, ApoB, Lp(a), CIMT, coronary calcium, hs-CRP, or any systemic labs. Those are yours.
- — We will not start peptide therapy, hormones, IV therapy, or systemic supplements.
- — We will not "co-manage" cardiovascular or cognitive risk. We manage the mouth and report what we find.
Four steps.
- 01
Send us the patient with any relevant labs, imaging, or notes.
- 02
We schedule the Periodontal Longevity Assessment.
- 03
You receive our written report within 5–7 business days of the assessment.
- 04
We coordinate ongoing maintenance and re-testing on a cadence you and the patient agree on.
A small network. No fees in either direction.
We maintain bidirectional relationships with a small number of Austin-area physician-led practices. There are no kickbacks, rebates, or referral fees in either direction. If you would like to be part of that network, contact us directly.
Direct line: (512) 660-5008
Physician email: info@bedrocklaserperio.com
Fax / secure referral: available on request
Our patient-facing brand is GumsMaxxing.com. All clinical materials, referral pads, and reports use the Bedrock Periodontal Longevity name.
The evidence base we work from.
In the order a physician would want to read it.
Cardiovascular
- — American Heart Association Scientific Statement (2025). Periodontal Disease and Atherosclerotic Cardiovascular Disease. source
- — Sanz M, et al. Periodontitis and cardiovascular diseases: EFP/WHF Consensus Report. J Clin Periodontol / Global Heart, 2020. source
- — Larvin H, et al. Risk of incident cardiovascular disease in people with periodontal disease: systematic review and meta-analysis of 32 cohort studies. Clin Exp Dent Res, 2020. Pooled RR 1.20 (95% CI 1.14–1.26); 1.25 for severe PD. source
- — Gianos E, Jackson EA, Tejpal A, et al. Oral health and atherosclerotic cardiovascular disease: A review. Am J Prev Cardiol, 2021;7:100179. source
- — Lockhart PB, et al. Periodontal Disease and Atherosclerotic Vascular Disease. AHA Scientific Statement. Circulation, 2012. source
Cognitive / Alzheimer's
- — Chen C-K, Wu Y-T, Chang Y-C. Association between chronic periodontitis and the risk of Alzheimer's disease. Alzheimer's Res Ther, 2017. source
- — Ma KS, et al. Dementia and the risk of periodontitis: a population-based cohort study. J Dent Res, 2022. Adjusted HR 1.67 (95% CI 1.24–2.23). source
- — Cichońska D, Mazuś M, Kusiak A. Recent aspects of periodontitis and Alzheimer's disease — a narrative review. Int J Mol Sci, 2024;25(5):2612. source
Physician-facing longevity framing
- — Peter Attia, MD. Don't underestimate the importance of oral health. Source of the 3.5× ASCVD / 1.7× Alzheimer's summary numbers we use in patient-facing copy. source
Diagnostic partners (physician-relevant validity data)
- — OralDNA MyPerioPath — CLIA-certified qPCR panel, 11 named periodontal pathogens (Quest subsidiary). source
- — Bristle — shotgun metagenomic sequencing, 700+ oral species; published AUC 0.88 for periodontitis classification. source
- — Viome Oral Health Intelligence / CancerDetect — RNA transcriptomic saliva test with FDA Breakthrough Device designation for oral and throat cancer screening. Not FDA-cleared; disclosed to patients in writing before consent. source